|
CNNM4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.14659956476737E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.41590000000081E-05 |
| Normal-vs-Stage2 |
1.000230E-02 |
| Normal-vs-Stage3 |
2.978200E-04 |
| Normal-vs-Stage4 |
6.518000E-02 |
| Stage1-vs-Stage2 |
2.105600E-01 |
| Stage1-vs-Stage3 |
1.999700E-02 |
| Stage1-vs-Stage4 |
1.670610E-01 |
| Stage2-vs-Stage3 |
2.949600E-01 |
| Stage2-vs-Stage4 |
7.630000E-01 |
| Stage3-vs-Stage4 |
6.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77959999461785E-08 |
| Normal-vs-AfricanAmerican |
4.2751000000063E-05 |
| Normal-vs-Asian |
1.595000E-01 |
| Caucasian-vs-AfricanAmerican |
7.916600E-01 |
| Caucasian-vs-Asian |
2.227800E-01 |
| AfricanAmerican-vs-Asian |
2.711800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.16750000000998E-07 |
| Normal-vs-Female |
3.97110000438516E-08 |
| Male-vs-Female |
4.519700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.324300E-03 |
| Normal-vs-Extreme_Weight |
6.567800E-04 |
| Normal-vs-Obese |
1.91605999999567E-05 |
| Normal-vs-Extreme_Obese |
3.671400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.360600E-01 |
| Normal_Weight-vs-Obese |
9.046400E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.590600E-01 |
| Extreme_Weight-vs-Obese |
2.213800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.848400E-01 |
| Obese-vs-Extreme_Obese |
2.028400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.415400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.36810016041034E-10 |
| Normal-vs-Age(61-80Yrs) |
7.66850000000208E-05 |
| Normal-vs-Age(81-100Yrs) |
1.123010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.829700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.064500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.112260E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.975810E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.379700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.374600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.00210000297807E-08 |
| Normal-VS-Type2 PRCC |
2.343700E-03 |
| Normal-VS-KIRP CIMP |
4.417500E-03 |
| Normal-VS-Unclassified PRCC |
2.0245999999946E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.385800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.638080E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.238000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.024240E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.824100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.722000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.550390E-02 |
| Normal-vs-N1 |
1.717220E-03 |
| Normal-vs-N2 |
6.476100E-02 |
| N0-vs-N1 |
1.188220E-02 |
| N0-vs-N2 |
3.295700E-03 |
| N1-vs-N2 |
9.077400E-01 |
|
|
